Consolidation Seen Changing Nature Of Indian Generics Industry
This article was originally published in PharmAsia News
Executive Summary
The face that India's pharmaceutical makers have presented to the rest of the industry may be changing. The Indian industry, comprised primarily of makers of generic drugs, has been undergoing a consolidation of late, a move likely to increase market power for the participants, but also reduce competition, thus increasing prices for consumers. The move by Ranbaxy Laboratories to sell to Japan's Daiichi Sankyo has led to speculation about the future of India's generics-making industry. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.